We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+11.53%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$57.2B
AUM Growth
+$4B
(+7.5%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-2.06%
Top 10 Holdings %
Top 10 Hldgs %
12.48%
Holding
3,271
New
835
Increased
795
Reduced
814
Closed
718
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$342M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$300M |
| 3 |
DFS
Discover Financial Services
DFS
|
+$270M |
| 4 |
Baker Hughes
BKR
|
+$249M |
| 5 |
Meta Platforms (Facebook)
META
|
+$220M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$650M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$424M |
| 3 |
Union Pacific
UNP
|
+$350M |
| 4 |
HES
Hess
HES
|
+$314M |
| 5 |
Deere & Co
DE
|
+$292M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.59% |
| 2 | Consumer Discretionary | 8.82% |
| 3 | Industrials | 8.12% |
| 4 | Financials | 7.95% |
| 5 | Healthcare | 5.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Sasol
SSL
$7.17B
| $108K | ﹤0.01% |
+13,801
| New | +$114K |
|
2452
ADC Therapeutics
ADCT
$134M
| $107K | ﹤0.01% |
+23,765
| New | +$87.7K |
|
|
LNAI
2453
Lunai Bioworks
LNAI
$10.2M
| $104K | ﹤0.01% |
492
+170
| +53% | +$45.9K |
|
2454
ARKO Corp
ARKO
$505M
| $104K | ﹤0.01% |
+18,206
| New | +$133K |
|
2455
Nomura Holdings
NMR
$29.2B
| $100K | ﹤0.01% |
+15,595
| New | +$86.6K |
|
|
CMRC
2456
Commerce.com Inc Series 1
CMRC
$184M
| $99.2K | ﹤0.01% |
+14,395
| New | +$115K |
|
|
NXDT
2457
NexPoint Diversified Real Estate Trust
NXDT
$261M
| $98.9K | ﹤0.01% |
+14,990
| New | +$99.6K |
|
2458
DocGo
DCGO
$64.5M
| $95.8K | ﹤0.01% |
+23,718
| New | +$89.5K |
|
2459
Tenaya Therapeutics
TNYA
$164M
| $95.5K | ﹤0.01% |
+18,267
| New | +$87.4K |
|
2460
Allogene Therapeutics
ALLO
$683M
| $95.3K | ﹤0.01% |
21,317
+5,587
| +36% | +$23.3K |
|
2461
Prospect Capital
PSEC
$1.18B
| $94.3K | ﹤0.01% |
+17,091
| New | +$98.4K |
|
2462
Offerpad Solutions
OPAD
$21.8M
| $93.6K | ﹤0.01% |
+1,156
| New | +$101K |
|
|
CNSL
2463
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $93.4K | ﹤0.01% |
21,621
-13,009
| -38% | -$56.6K |
|
2464
Joby Aviation
JOBY
$8.17B
| $89.9K | ﹤0.01% |
+16,773
| New | +$95.1K |
|
2465
Capricor Therapeutics
CAPR
$244M
| $88.2K | ﹤0.01% |
+12,994
| New | +$62.8K |
|
2466
Sabre
SABR
$892M
| $86.3K | ﹤0.01% |
+35,645
| New | +$120K |
|
|
TSBX
2467
DELISTED
Turnstone Biologics
TSBX
| $85.8K | ﹤0.01% |
+32,746
| New | +$93.7K |
|
2468
Lexicon Pharmaceuticals
LXRX
$1.04B
| $82.6K | ﹤0.01% |
+34,433
| New | +$74K |
|
2469
Intuitive Machines
LUNR
$2.82B
| $80K | ﹤0.01% |
+12,797
| New | +$60.8K |
|
2470
Atossa Therapeutics
ATOS
$25.5M
| $77.4K | ﹤0.01% |
+2,865
| New | +$46K |
|
|
GOEV
2471
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $76.6K | ﹤0.01% |
+1,073
| New | +$74.7K |
|
|
RGLS
2472
DELISTED
Regulus Therapeutics
RGLS
| $69.8K | ﹤0.01% |
+24,253
| New | +$39.6K |
|
2473
CytomX Therapeutics
CTMX
$730M
| $69.6K | ﹤0.01% |
+31,921
| New | +$58.9K |
|
2474
Bridger Aerospace
BAER
$73.5M
| $67.6K | ﹤0.01% |
+13,459
| New | +$74.6K |
|
|
GTHX
2475
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $67.5K | ﹤0.01% |
+15,614
| New | +$54.4K |
|
Similar funds
BC
Balyasny Asset Management's Q1 2024 Portfolio in Review
As of Q1 2024, Balyasny Asset Management held 3,271 positions worth $57.2B, up 7.5% from $53.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Balyasny Asset Management's Q1 2024 filing shows 835 new, 795 increased, 814 reduced and 718 closed positions. Its largest new stake was Public Service Enterprise Group: 2,419,537 shares worth $162M. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $650M.
By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 9.2% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Balyasny Asset Management's largest Q1 2024 buy was Public Service Enterprise Group: 2,419,537 shares worth $162M.
- Balyasny Asset Management added most to Broadcom in Q1 2024, an estimated $342M increase.
- Balyasny Asset Management's biggest Q1 2024 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $650M.
- Balyasny Asset Management fully exited Splunk Inc in Q1 2024, selling an estimated $263M.
- Balyasny Asset Management's ten largest holdings make up 12% of its $57.2B portfolio in Q1 2024.
- Balyasny Asset Management opened 835 new positions and closed 718 in Q1 2024.
- Balyasny Asset Management's portfolio value rose 7.5% quarter-over-quarter to $57.2B.
Based on Balyasny Asset Management's 13F filing for Q1 2024, filed 13 May 2024.